Mumbai (Maharashtra) [India], May 18 (ANI/SRV): Metropolis Healthcare Limited, India's leading diagnostic service provider, announces the launch of a novel testing platform based on Component Resolved Diagnostics (CRD) to support India's population in diagnosing various forms of allergies. This 4th generation allergy testing technology uses Artificial Intelligence to assist clinicians in making sound clinical decisions and provides great insights into selecting and optimizing the course of treatment regarding an individual's allergic disease.
